Background: Helicobacter pylori (H.pylori) is a gramnegative flagellated spiral bacterium which is usually acquired during childhood, and the infection persists throughout life unless specifically treated. Resistance against H.pylori is increasing, and it is necessary to find new effective agents. Nigella sativa has possible role of N. sativa oil in eradication of H.pylori infection in symptomatic children.
Introduction
HELICOBACTER pylori (H.pylori) is a gramnegative flagellated spiral bacterium which is usually acquired during childhood, and the infection persists throughout life unless specifically treated [1] . The possible routes of infection are feco oral, oro oral and gastro oral [2] .
The prevalence of H.pylori infection among children is diverse and dependent on many factors. Lower prevalence rates are reported in communities with higher socioeconomic status and generally better environmental conditions, while the highest percentage of infected children is observed in developing countries [3] . Prevalence of H.pylori infection in Egyptian children at age of 5-15 years is about 50% [4] .
Generally, only a small proportion of H.pylori infected children develop symptoms which are non specific and may include epigastric pain especially after meals, night-time waking, unexplained nausea and/or vomiting, anorexia, hematemesis, and irondeficiency anemia [5] .
The relationship of H.pylori infection with growth retardation in children is controversial. However, in poor resource settings where malnutrition, parasitic/enteropathogen, and H.pylori infection coexist in young children, H.pylori might play a potential role [6] .
H.pylori is the causative agent of chronic gastritis and peptic ulcer diseases and is an important risk factor for the development of gastric cancer and Mucosal-Associated Lymphoid Tissue (MALT) lymphoma [7] .
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Diagnosis of H.pylori may be through invasive or non invasive techniques. Invasive tests include an Upper Gastrointestinal Endoscopy (UGIE) and biopsy for detection of organism itself or catalase reaction. Non invasive tests include serology, detection of H.pylori antibodies in urine and saliva, Urea Breath Test (UBT), and stool antigen test [8] .
Stool antigen test is an excellent tool in diagnosing H.pylori infection and confirming eradication in children after treatment through detecting bacterial antigen in stools using monoclonal antibodies [8] .
Triple therapy including clarithromycin with metronidazole and proton pump inhibitors is the standard therapy for H.pylori eradication as H.pylori has a peculiar habitat and characteristics, it is difficult to eradicate with a single antibiotic oral amoxicillin may replace one of the two anti microbials in the triple therapy [9] .
Studies revealed that H.pylori has been found to be resistant to one or more of the antimicrobial drugs of the triple therapy [10] . The rising prevalence of H.pylori antibiotic resistance emphasizes the need for discovery of new and safe modalities for treatment of H.pylori infection and the resulting gastroduodenal disease. It has been shown that essential oils extracted from plants like Nigella sativa oil are bactericidal against H.pylori without the development of acquired resistance, suggesting that essential oils may have potential benefit as new and safe agents for inclusion in anti-H.pylori regimens [11] .
A study was conducted in Saudi Arabia using Nigella sativa oil with proton pump inhibitors to treat H.pylori adult with non ulcer dyspeptic symptoms. The results were encouraging [12] .
Subjects and Methods
This randomized clinical trial was carried out on 60 symptomatic children proven positive for H.pylori stool antigen test from those attending the Diarrheal Diseases and Nutrition Unit of Pediatric Department at Tanta University Hospital in the period between June/2017 to May/2018. The patients were randomly assigned to one of the following three groups: According to this scale we divided patients with dyspepsia into three groups: Mild (score <6), moderate (score 7-10) and severe (score >11) [13] .
C-Clinical examination.
D-Investigations including: Complete blood count,
blood urea nitrogen and serum creatinine, Aspartate aminotransferase (AST) and alanine aminotransferase (ALT), Erythrocyte Sedimentation Rate (ESR), occult blood in stool, H.pylori antigen in stool after treatment using ELISA.
E-Reassessment of severity of dyspepsia using "Modified Glasgow Dyspepsia Severity Score" after treatment. 
Results
Table (1) showed the distribution of demographic data in studied groups. There was no statistically significant differences between the three groups. Table ( 2) showed symptoms in studied groups. There was no statistically differences between the three groups. The most common presenting symptoms in the studied patients were abdominal pain (83.33%) and vomiting (63.33). Precipitating factors including meals, stress and sleep were evident in 71.67% of studied patients. Table ( 3) showed history of non-gastrointestinal symptoms in the studied groups. There was no statistically significant differences between the three groups as regard positive history of headache, migraine, sweating, pallor and dizziness. Positive history for pallor and headache were found in 53.33% and 45% of patients respectively.
Table (4) showed the family history in the studied groups. There was no statistically significant differences between the three studied groups as regard positive family history of gastrointestinal disorders, school problems, death and divorce. Before After Fig. (1) : The modified Glasgow dyspepsia score in the studied groups before and after treatment.
Table (5) and Fig. (1) showed modified Glasgow dyspepsia score in the studied groups before and after treatment. Within the same group, modified Glasgow dyspepsia score showed significant improvement in each of the studied groups on comparing values before and after treatment. On comparing studied groups, there was no significant differences between the mean score values in the three studied groups before treatment; while after treatment, significant differences were found on comparing either Group I or Group III versus Group II. The mean score value was significantly lower in Group III compared to both Groups I and II.
Table (6) and Fig. ( 2) showed the result of H.pylori antigen in stool in studied groups after treatment. There was statistically significant differences between the three studied groups. The difference was evident on comparing either Group I or Group III versus Group II. Significantly more cases in Group I (65%) and in Group III (75%) became negative to H.pylori antigen in stool in comparison to only (30%) of the patients in Group II.
Positive Negative
Group I Group II Group III Fig. (2) : H.pylori antigen in stool after treatment in the studied groups. 
Discussion
Successful treatment of H.pylori infection with antimicrobial agents can lead to regression of H.pylori-associated disorders. The main reasons for treatment failure are antimicrobial resistance, patient non-adherence and the complexity of the therapy, so it is necessary to find new effective agents [14] .
Natural compounds have found their applications in the treatment of refractory diseases. Because of their satisfactory clinical efficacy and low toxicity, N.sativa is one of the oldest documented herbal medicinal plants and has been used for centuries in traditional Arabic medicine [15] .
The aim of this study to evaluate the possible role of N.sativa oil in eradication of H.pylori infection in symptomatic children.
This study was conducted on 60 children having complains of dyspeptic symptoms and had positive result for H.pylori infection with age ranged between 5-15 years.
In our study, the (mean ± SD) age of the enrolled children was 9.5-11.2 ± 2.9 years in the three studied groups. This agreed with Hasosah et al., 2015 who studied prevalence of H.pylori infection in children where H.pylori infection was more evident (57.7%) in the 10 year age group while in the study by Abu Zekry, 2013 who studied frequency of H.pylori infection among Egyptian children presenting with gastrointestinal manifestations the mean age was was 7.37 ±3.0 years.
Age was identified as one of the most important risk factors for H.pylori acquisition. Early childhood is the age of acquisition of H. pylori infection in developing countries, whereas in developed countries, infection is acquired after the age of 10 years [16] .
As regard gender in our study, 22 (36.66%) were males and 38 (63.33%) were females with male (m):female (f) ratio 1:1.7. This is agreed with Hasosah et al., 2015 which study included 149 males 49.2% for males and 154 (50.8) for females with m:f ratio about 1:1. While in Abu-Zekry, 2013 study 81 (54%) of the patients were boys and 69 (46%) were girls with m:f 1.17:1.
According to residence in our study, 40 (66.66%) children came from rural areas and 20 (33.33%) children came from urban areas. In agreement with our study, Hanafi, 2013 study conducted to determine the seroprevalence of H.pylori in asymptomatic healthy individuals and the possible relationship between H.pylori infection and socio demographic, lifestyle, and environmental factors, he found that H.pylori seropositivity was significantly more frequently encountered among individuals who came rural areas (55.4%) than among urban residents (44.6%). In contrast to Ghasemi Kebria, 2013 study in which 106 (54.6%) children were comed from urban areas and 88 (45.4%) were from rural areas.
In the present study, it was observed that the common presenting symptoms was abdominal pain. In our study 50 children (83.33%) had abdominal pain this agreed with both Correa Silva, 2016 study and Abu-Zekry, 2013 study who reported that (86%) and (82%) of children infected with H.pylori had abdominal pain respectively. While in Hasosah et al., 2015 study abdominal pain was found in (57.28%) children.
The second main presenting symptoms in our study was vomiting in 38 (63.33%) of studied children. This is in agreement with Raj, 2017 who studied the efficacy of H.pylori serology test in screening symptomatic children, vomiting percentage in H.pylori infected patient was 46%. Also Hasosah et al., 2015 reported that 32 (41.56%) children who are positive for H.pylori had vomiting.
In our study also, 14 (23.33%) children had weight loss. This agreed with Raj, 2017 study in which 17% of H.pylori infected children had weight loss.
In the present study 43 (71.67%) children had priciptating factors for dyspepsia as meals, stress and sleep. Similar findings were reported by Spiroglou et al., 2004 who studied the frequency, clinical manifestations and treatment of functional dyspepsia in childhood, in which 107 (30.74%) children had priciptating factors.
Also in our study it was found that 27 (45%) children had headache and this did not agree with Spiroglou et al., 2004 study in which 41 (11.78%) had headache.
In the present study, 8 (13.33%) children had migraine this did not agree with Spiroglou et al., 2004 study in which 4 (.86%) had migraine.
In our study, 16 (26. H.pylori infection occurs essentially in childhood, mostly in the family, the mother being the main source [23] . Mother-to-child transmission was strongly suggested in a study of DNA analysis of the H.pylori strains. The data showed identical H.pylori strains between mothers and their toddleraged children. Moreover, the mother who had nausea and vomiting and the use of pacifier for her child were significantly associated with the risk of H.pylori infection in children [24] .
Psychological stress and negative life events e.g. school problems, death and divorce has long been recognized as a risk factor for the development of dyspepsia in children. Therefor a particular attention was given to this part of the history in our study [25] .
In the present study 19 (31.67%) children had history of school problems, 19 (31.67) had positive family history of death and 8 (13.33%) had positive family divorce.
In our study as regard total modified glasgow dyspepsia severity score, within the same group, it showed significant improvement in each of the three studied groups on comparing values before and after treatment. In the present study on comparing studied groups, there was no significant differences between the mean score values in the three studied groups before treatment; while after treatment, significant differences were found on comparing either Group I or Group III versus Group II. The mean score value was significantly lower in Group III compared to both Groups I and II. Reduction in dyspeptic symptoms was more likely due to the action of N.sativa oil and omeprazole. There are recent studies which show that aqueous suspension of N.sativa has anti-secretory effects and a protective role for gastric mucosa against injury induced by necrotizing agents and omeprazole is documented to reduce the symptoms in functional dyspepsia as a result of decreasing the gastric acid secretion and increasing the stomach pH [12] .
The most commonly recommended triple H.pylori regimen including a Proton Pump Inhibitor (PPI), and a combination of amoxicillin/ metrinodazole and clarithromycin now provide unacceptably low treatment success [26] .
In light of emerging resistance, there is a need to look for new remedies effective against H.pylori. It has been shown that essential oils, extracted from plants, are bactericidal against H.pylori without the development of acquired resistance, suggesting that essential oils may have potential as new and safe agents for inclusion in anti H.pylori regimens. Diethyl-ether extract of N.sativa has been reported to inhibit gram-positive and gramnegative bacteria, as well as pathogenic yeast. Recently, crude extracts of N.sativa were reported to have a promising effect on multi-drug resistant organisms, including gram-positive and gramnegative bacteria [12] . Salem et al., studied the effectiveness of N.sativa oil in eradication of H.pylori in adult patient with non-ulcer dyspepsia compared to the conventional triple therapy and the results encouraged us to study its role in children for the first time.
In the present study, the result showed that triple therapy in Group I significantly eradicate H.pylori in (65%) of studied children and addition of N.sativa oil to the triple therapy in Group III increased the proportion of eradication to (75%) of studied children.
In Group II, administration of N.sativa oil combined with PPI alone eradicated H.pylori in (30%) of studied children. Salem et al., 2010 in their study on adults compared triple therapy with N.sativa oil. Their results showed that N.sativa oil eradicated H.pylori in infected patients in a proportion (67%) which i s close to that of standard triple therapy (82.6%).
Conclusion:
Addition of N.sativa to the traditional triple therapy increased the probability of H.pylori eradication more than that achieved through triple therapy alone.
Recommendation:
• Addition of N.sativa oil in dose of 2gm/day to triple therapy in management of H.pylori infection in symptomatic children is more effective.
• Further studies using different doses of N.sativa oil is suggested to assess their effects on childhood dyspepsia.
• Further studies are recommended for assessment of N.sativa oil effect on drug-resistant H.pylori in those receiving many consecutive courses of triple therapy.
